Your browser doesn't support javascript.
loading
Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma.
Bouchereau, Sarah; Chaplain, Louise; Fort, Magali; Beauchet, Alain; Sidibé, Thomas; Chapalain, Marie; Gonzalez-Lara, Leire; Longvert, Christine; Blom, Astrid; Saiag, Philippe; Funck-Brentano, Elisa.
Afiliação
  • Bouchereau S; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Chaplain L; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Fort M; Research unit EA4340 'Biomarkers and clinical trials in cancerology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Boulogne-Billancourt, France.
  • Beauchet A; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Sidibé T; Department of Public Health, GHU Paris-Saclay, AP-HP, Boulogne-Billancourt, France.
  • Chapalain M; Department of Pharmacy, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Gonzalez-Lara L; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Longvert C; Research unit EA4340 'Biomarkers and clinical trials in cancerology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Boulogne-Billancourt, France.
  • Blom A; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
  • Saiag P; Research unit EA4340 'Biomarkers and clinical trials in cancerology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Boulogne-Billancourt, France.
  • Funck-Brentano E; Department of General and Oncologic Dermatology, Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, France.
Br J Cancer ; 125(7): 948-954, 2021 09.
Article em En | MEDLINE | ID: mdl-34262147

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Dacarbazina / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antineoplásicos Alquilantes / Dacarbazina / Inibidores de Checkpoint Imunológico / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article